New Delhi, Aug 18 (NationPress) The Technology Development Board (TDB), operating under the Department of Science and Technology, has announced its support for a locally developed AI-powered blood testing device aimed at enhancing primary healthcare, as stated by the Ministry of Science and Technology on Monday.

The TDB has formalized a partnership with New Delhi-based Primary Healthtech for the initiative titled “IoT-enabled point-of-care blood testing device for affordable and accessible healthcare powered by AI/ML algorithms.”

“This project aims to improve the existing prototype (M1) to conduct five tests simultaneously, thereby minimizing patient waiting times and establishing commercial-scale manufacturing. The next-generation Mobilab will incorporate tests for haemoglobin, creatinine, bilirubin, cholesterol, triglycerides, uric acid, glucose, and gamma-glutamyl transferase (GGT), among others,” the Ministry stated.

Mobilab, previously developed by the company, is a portable, battery-operated clinical chemistry analyzer designed by Primary Healthtech. This device is IoT-enabled and utilizes AI/ML algorithms, capable of analyzing over 25 parameters related to kidney, liver, heart, vitamins, and cancer health.

“Providing quality healthcare access in rural and remote areas is a national priority. This initiative not only addresses issues of affordability and accessibility but also showcases India’s potential in creating indigenous, AI-powered diagnostic solutions for primary healthcare,” said Rajesh Kumar Pathak, Secretary of TDB.

This collaboration highlights TDB’s dedication to promoting local healthcare innovations that align with Atmanirbhar Bharat and bolstering India’s role in affordable medical technologies on a global scale.

Primary Healthtech, founded by alumni of IIT Guwahati, is committed to developing affordable diagnostic technologies tailored for underserved populations.

The company holds a patent for “a transmittance-based system/kit for point-of-care quantification” transferred from IIT Guwahati and has filed over six additional patent applications related to integrated mixers, assay development, centrifuges, and proprietary optical systems. The device has already been tested on 10,000 patients and recently obtained a CDSCO manufacturing license.

“With Mobilab, we aim to bridge the healthcare divide for rural and underserved communities, ensuring that advanced diagnostics are accessible at the point of care, anywhere in India,” stated the promoters of Primary Healthtech.